162 related articles for article (PubMed ID: 16048334)
1. Using peptidic inhibitors to systematically probe the S1' site of caspase-3 and caspase-7.
Goode DR; Sharma AK; Hergenrother PJ
Org Lett; 2005 Aug; 7(16):3529-32. PubMed ID: 16048334
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.
Ekici OD; Li ZZ; Campbell AJ; James KE; Asgian JL; Mikolajczyk J; Salvesen GS; Ganesan R; Jelakovic S; Grütter MG; Powers JC
J Med Chem; 2006 Sep; 49(19):5728-49. PubMed ID: 16970398
[TBL] [Abstract][Full Text] [Related]
3. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
Fang B; Boross PI; Tozser J; Weber IT
J Mol Biol; 2006 Jul; 360(3):654-66. PubMed ID: 16781734
[TBL] [Abstract][Full Text] [Related]
4. Reducing the peptidyl features of caspase-3 inhibitors: a structural analysis.
Becker JW; Rotonda J; Soisson SM; Aspiotis R; Bayly C; Francoeur S; Gallant M; Garcia-Calvo M; Giroux A; Grimm E; Han Y; McKay D; Nicholson DW; Peterson E; Renaud J; Roy S; Thornberry N; Zamboni R
J Med Chem; 2004 May; 47(10):2466-74. PubMed ID: 15115390
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of potent beta-secretase (BACE1) inhibitors with P1' carboxylic acid bioisosteres.
Kimura T; Hamada Y; Stochaj M; Ikari H; Nagamine A; Abdel-Rahman H; Igawa N; Hidaka K; Nguyen JT; Saito K; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2006 May; 16(9):2380-6. PubMed ID: 16481167
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of vinyl sulfones as caspase-3 inhibitors. A structure-activity study.
Newton AS; Glória PM; Gonçalves LM; dos Santos DJ; Moreira R; Guedes RC; Santos MM
Eur J Med Chem; 2010 Sep; 45(9):3858-63. PubMed ID: 20541849
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central core.
Björklund C; Adolfsson H; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2010 Feb; 18(4):1711-23. PubMed ID: 20122837
[TBL] [Abstract][Full Text] [Related]
8. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Grembecka J; Mucha A; Cierpicki T; Kafarski P
J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
[TBL] [Abstract][Full Text] [Related]
9. Solid phase synthesis of selective caspase-3 peptide inhibitors.
Grimm EL; Roy B; Aspiotis R; Bayly CI; Nicholson DW; Rasper DM; Renaud J; Roy S; Tam J; Tawa P; Vaillancourt JP; Xanthoudakis S; Zamboni RJ
Bioorg Med Chem; 2004 Mar; 12(5):845-51. PubMed ID: 14980595
[TBL] [Abstract][Full Text] [Related]
10. Effect of caspase cleavage-site phosphorylation on proteolysis.
Tözsér J; Bagossi P; Zahuczky G; Specht SI; Majerova E; Copeland TD
Biochem J; 2003 May; 372(Pt 1):137-43. PubMed ID: 12589706
[TBL] [Abstract][Full Text] [Related]
11. A strategy to profile prime and non-prime proteolytic substrate specificity.
Petrassi HM; Williams JA; Li J; Tumanut C; Ek J; Nakai T; Masick B; Backes BJ; Harris JL
Bioorg Med Chem Lett; 2005 Jun; 15(12):3162-6. PubMed ID: 15878267
[TBL] [Abstract][Full Text] [Related]
12. Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors.
Ganesan R; Jelakovic S; Campbell AJ; Li ZZ; Asgian JL; Powers JC; Grütter MG
Biochemistry; 2006 Aug; 45(30):9059-67. PubMed ID: 16866351
[TBL] [Abstract][Full Text] [Related]
13. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
Blanchard H; Donepudi M; Tschopp M; Kodandapani L; Wu JC; Grütter MG
J Mol Biol; 2000 Sep; 302(1):9-16. PubMed ID: 10964557
[TBL] [Abstract][Full Text] [Related]
14. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
Yavin EJ; Eisenstein M; Fridkin M
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
[TBL] [Abstract][Full Text] [Related]
15. Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions.
Tagad HD; Hamada Y; Nguyen JT; Hamada T; Abdel-Rahman H; Yamani A; Nagamine A; Ikari H; Igawa N; Hidaka K; Sohma Y; Kimura T; Kiso Y
Bioorg Med Chem; 2010 May; 18(9):3175-86. PubMed ID: 20381362
[TBL] [Abstract][Full Text] [Related]
16. Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors.
Mellon C; Aspiotis R; Black CW; Bayly CI; Grimm EL; Giroux A; Han Y; Isabel E; McKay DJ; Nicholson DW; Rasper DM; Roy S; Tam J; Thornberry NA; Vaillancourt JP; Xanthoudakis S; Zamboni R
Bioorg Med Chem Lett; 2005 Sep; 15(17):3886-90. PubMed ID: 16023344
[TBL] [Abstract][Full Text] [Related]
17. In situ assembly of enzyme inhibitors using extended tethering.
Erlanson DA; Lam JW; Wiesmann C; Luong TN; Simmons RL; DeLano WL; Choong IC; Burdett MT; Flanagan WM; Lee D; Gordon EM; O'Brien T
Nat Biotechnol; 2003 Mar; 21(3):308-14. PubMed ID: 12563278
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8.
James KE; Asgian JL; Li ZZ; Ekici OD; Rubin JR; Mikolajczyk J; Salvesen GS; Powers JC
J Med Chem; 2004 Mar; 47(6):1553-74. PubMed ID: 14998341
[TBL] [Abstract][Full Text] [Related]
19. Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.
Agniswamy J; Fang B; Weber IT
FEBS J; 2007 Sep; 274(18):4752-65. PubMed ID: 17697120
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional analysis of caspase active sites.
Chéreau D; Kodandapani L; Tomaselli KJ; Spada AP; Wu JC
Biochemistry; 2003 Apr; 42(14):4151-60. PubMed ID: 12680769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
